Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.08% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Financials | 2.23% |
| 4 | Healthcare | 2.22% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
CALL
Lemonade
LMND
$4.1B
| $41.1M | 0.01% |
613,700
+73,100
| +14% | +$5.89M |
|
1227
CALL
CRISPR Therapeutics
CRSP
$5.22B
| $41.1M | 0.01% |
367,100
-24,000
| -6% | -$3.01M |
|
1228
Hyatt Hotels
H
$16.8B
| $41M | 0.01% |
532,244
+427,189
| +407% | +$32.2M |
|
1229
CALL
Progressive
PGR
$121B
| $41M | 0.01% |
453,500
-10,400
| -2% | -$991K |
|
1230
Commercial Metals
CMC
$7.98B
| $40.9M | 0.01% |
1,344,044
+1,063,365
| +379% | +$33.9M |
|
1231
NetApp
NTAP
$40.2B
| $40.9M | 0.01% |
456,109
+297,309
| +187% | +$25.1M |
|
1232
SkinHealth Systems
SKIN
$85.9M
| $40.8M | 0.01% |
1,571,054
-1,586,464
| -50% | -$34.9M |
|
1233
Olema Pharmaceuticals
OLMA
$913M
| $40.7M | 0.01% |
1,477,055
+40,576
| +3% | +$1.1M |
|
1234
Carter's
CRI
$1.44B
| $40.5M | 0.01% |
416,348
+107,472
| +35% | +$10.8M |
|
1235
PUT
Teleflex
TFX
$5.82B
| $40.5M | 0.01% |
107,500
-11,000
| -9% | -$4.28M |
|
1236
PUT
Fiverr
FVRR
$311M
| $40.4M | 0.01% |
221,000
+75,000
| +51% | +$15.1M |
|
|
PSTH
1237
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $40.4M | 0.01% |
2,048,824
+1,212,806
| +145% | +$24.6M |
|
1238
Ericsson
ERIC
$33.6B
| $40.4M | 0.01% |
3,603,697
+3,091,404
| +603% | +$36.5M |
|
1239
PUT
3D Systems Corp
DDD
$601M
| $40.3M | 0.01% |
1,463,200
-258,500
| -15% | -$7.65M |
|
1240
Edgewise Therapeutics
EWTX
$4.69B
| $40.3M | 0.01% |
2,425,184
-34,967
| -1% | -$632K |
|
|
LSI
1241
DELISTED
Life Storage, Inc.
LSI
| $40.2M | 0.01% |
350,498
+79,943
| +30% | +$9.51M |
|
|
IMGO
1242
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $40.1M | 0.01% |
+2,042,439
| New | +$43.8M |
|
1243
CALL
TripAdvisor
TRIP
$1.26B
| $40.1M | 0.01% |
1,183,600
-322,500
| -21% | -$11.6M |
|
|
WBA
1244
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $40M | 0.01% |
851,100
-170,900
| -17% | -$8.24M |
|
1245
CALL
Tyson Foods
TSN
$19.8B
| $40M | 0.01% |
506,400
+33,200
| +7% | +$2.51M |
|
1246
CALL
Novartis
NVS
$288B
| $40M | 0.01% |
488,800
+139,600
| +40% | +$12.6M |
|
1247
Booz Allen Hamilton
BAH
$9.43B
| $39.9M | 0.01% |
502,706
+406,055
| +420% | +$33.9M |
|
1248
CALL
Cracker Barrel
CBRL
$1.31B
| $39.8M | 0.01% |
284,800
+67,000
| +31% | +$9.38M |
|
1249
CALL
Ambarella
AMBA
$3.6B
| $39.8M | 0.01% |
255,700
+153,300
| +150% | +$17.6M |
|
1250
Hubbell
HUBB
$26.8B
| $39.8M | 0.01% |
220,051
+174,047
| +378% | +$34M |
|
Similar funds
Ken Griffin's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
- Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.